Budget negotiation for industry-sponsored clinical trials

被引:4
|
作者
Beal, K
Dean, J
Chen, J
Dragaon, E
Saulino, A
Collard, CD
机构
[1] St Lukes Episcopal Hosp, Texas Heart Inst, Div Cardiovasc Anesthesiol, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Anesthesiol, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源
ANESTHESIA AND ANALGESIA | 2004年 / 99卷 / 01期
关键词
D O I
10.1213/01.ANE.0000122633.97424.76
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The specialty of anesthesia is well suited to attract industry-sponsored clinical trials and research revenues because of its fundamental contributions to surgery, critical care, and pain medicine. However, the performance and budgeting of industry-sponsored clinical research over the past decade has been significantly altered by the rapid growth of commercially oriented networks of contract-research organizations and site-management organizations. Further, the competitive nature of today's clinical research climate can make the planning and negotiating of study budgets and contracts stressful, time consuming, frustrating, and full of pitfalls. Because a clinical trial contract is a fixed-price agreement, investigators are obligated to perform the work described in the contract, even if the actual costs exceed the study contract. Successful budgeting for the performance of an industry-sponsored clinical trial thus requires a thorough understanding of the direct and indirect costs associated with performing clinical research. We reviewed budget and contractual considerations for the successful negotiation and performance of industry-sponsored clinical research.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [1] Industry-sponsored clinical trials: time to publication
    Mathias, Marla
    LaFlamme, K. Elizabeth
    Johnson, Tracy H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 : S12 - S12
  • [2] Industry-sponsored clinical trials and medical publishing
    N. J. C. Snell
    [J]. International Journal of Pharmaceutical Medicine, 2001, 15 (5) : 217 - 218
  • [3] Ethical considerations in industry-sponsored Multiregional Clinical Trials
    Ibia, Ekopimo
    Binkowitz, Bruce
    Saillot, Jean-Louis
    Talerico, Steven
    Koerner, Chin
    Ferreira, Irene
    Agarwal, Anupam
    Metz, Craig
    Maman, Marianne
    [J]. PHARMACEUTICAL STATISTICS, 2010, 9 (03) : 230 - 241
  • [4] Development of an authorship algorithm for industry-sponsored clinical trials
    Fusaro, Gina
    Matheis, Robert
    Weigel, Al
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 : S13 - S13
  • [5] Mitigating Administrative Risks in Industry-sponsored Clinical Trials
    Kim, Paul J.
    [J]. JOURNAL OF FOOT & ANKLE SURGERY, 2011, 50 (06): : 633 - 634
  • [6] Medical journals, academia, and industry-sponsored clinical trials
    Frighi, V
    [J]. PLOS MEDICINE, 2005, 2 (07) : 686 - 686
  • [7] Viewpoint: Professional integrity in industry-sponsored clinical trials
    Miller, FG
    Brody, H
    [J]. ACADEMIC MEDICINE, 2005, 80 (10) : 899 - 904
  • [8] Recent trends and controversies in industry-sponsored clinical trials
    Reed, CR
    Camargo, CA
    [J]. ACADEMIC EMERGENCY MEDICINE, 1999, 6 (08) : 833 - 839
  • [9] Emergency medicine leadership in industry-sponsored clinical trials
    Newgard, CD
    Kim, S
    Camargo, CA
    [J]. ACADEMIC EMERGENCY MEDICINE, 2003, 10 (02) : 169 - 174
  • [10] The potential for bias in reporting of industry-sponsored clinical trials
    Pyke, Stephen
    Julious, Steven A.
    Day, Simon
    O'Kelly, Michael
    Todd, Susan
    Matcham, James
    Seldrup, Jorgen
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (01) : 74 - 79